Royalty Pharma plc
RPRXCIK 0001802768 · last filing Jul 2, 2026
Insider signal
trades dated in the last 90 days · non-derivative only
0 bought / 139,099 sold
net −139,099 sh · −$7.85M
- buys
- 0
- sells
- 5
- insiders active
- 2
Filing tape
Filed Thu, Jul 2, 2026
- −9,099 sh · $508.5K
Urist Marshall — EVP, Research & Investments
- Sold9,099Class A Ordinary Shares@ $55.88→ 0 held
- −130,000 sh · $7.35M
Hite Christopher — EVP & Chairman, Partnering
- Sold97,446Class A Ordinary Shares@ $56.50→ 461,953 held
- Sold2,554Class A Ordinary Shares@ $57.10→ 459,399 held
- Sold29,400Class A Ordinary Shares@ $56.44→ 40,600 held
- Sold600Class A Ordinary Shares@ $57.09→ 40,000 held
Insiders on this tape
- Urist MarshallEVP, Research & Investments
- Hite ChristopherEVP & Chairman, Partnering
Informational data only — not investment advice.
The institutional holdings shown here are aggregated from third-party public regulatory filings (such as SEC Form 13F). These filings are reported with a delay (generally up to 45 days after each quarter-end), are backward-looking, and may exclude short positions, non-U.S. holdings, cash, and other assets. The data may contain errors, omissions, misclassifications, or gaps, and may not reflect a manager's current positions.
All figures are provided on an "as is" basis for general information only. Nothing on this page is financial, investment, or trading advice, a recommendation, or an endorsement of any security, manager, or strategy. Do not rely on it. Independently verify any figure against the original filings and consult a qualified professional before making any financial decision. Your use is subject to our Terms of Service.